WHY DO SO MANY HAEMOPHILIA A PATIENTS DEVELOP AN INHIBITOR?
- 1 July 1995
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 90 (3), 498-501
- https://doi.org/10.1111/j.1365-2141.1995.tb05575.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Large‐scale oligonucleotide typing for HLA‐DRB1/3/4 and HLA‐DQB1 is highly accurate, specific, and reliableTissue Antigens, 1993
- Inversions disrupting the factor VIII gene are a common cause of severe haemophilia ANature Genetics, 1993
- Incidence of inhibitors in haemophiliacs. A review of the literatureBlood Coagulation & Fibrinolysis, 1993
- Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIThe Lancet, 1993
- Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.The Journal of Experimental Medicine, 1993
- Spectrum of Mutations in CRM-Positive and CRM-Reduced Hemophilia AGenomics, 1993
- Analyis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patientsHuman Molecular Genetics, 1993
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcomeBritish Journal of Haematology, 1990
- Genetic predisposition to develop factor VIII antibody in classic hemophiliaClinical Immunology and Immunopathology, 1977